News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
300,996 Results
Type
Article (15305)
Company Profile (286)
Press Release (285405)
Section
Business (93935)
Career Advice (193)
Deals (15847)
Drug Delivery (47)
Drug Development (52194)
Employer Resources (39)
FDA (6428)
Job Trends (6693)
News (164025)
Policy (11139)
Tag
Academia (986)
Alliances (23887)
Alzheimer's disease (804)
Antibody-drug conjugate (ADC) (74)
Approvals (6411)
Artificial intelligence (101)
Bankruptcy (108)
Best Places to Work (5385)
Biotechnology (235)
Breast cancer (132)
Cancer (1121)
Cardiovascular disease (95)
Career advice (166)
CAR-T (97)
Cell therapy (274)
Clinical research (41810)
Collaboration (433)
Compensation (160)
COVID-19 (1089)
C-suite (113)
Cystic fibrosis (74)
Data (1125)
Diabetes (108)
Diagnostics (1936)
Earnings (35544)
Events (50064)
Executive appointments (370)
FDA (6918)
Funding (417)
Gene therapy (200)
GLP-1 (380)
Government (1211)
Healthcare (7924)
Infectious disease (1142)
Inflammatory bowel disease (102)
IPO (8356)
Job creations (1614)
Job search strategy (159)
Layoffs (209)
Legal (1544)
Lung cancer (167)
Lymphoma (73)
Manufacturing (133)
Medical device (3914)
Medtech (3916)
Mergers & acquisitions (7739)
Metabolic disorders (333)
Neuroscience (1108)
NextGen: Class of 2025 (2446)
Non-profit (1054)
Northern California (1322)
Obesity (182)
Opinion (101)
Parkinson's disease (89)
Patents (74)
People (28956)
Phase I (14952)
Phase II (19390)
Phase III (12251)
Pipeline (512)
Postmarket research (893)
Preclinical (6111)
Radiopharmaceuticals (217)
Rare diseases (236)
Real estate (3161)
Regulatory (9268)
Research institute (1014)
Series A (79)
Southern California (1199)
Startups (2130)
United States (10750)
Vaccines (206)
Weight loss (115)
Date
Today (119)
Last 7 days (394)
Last 30 days (1712)
Last 365 days (22464)
2025 (1716)
2024 (22583)
2023 (24688)
2022 (31084)
2021 (32253)
2020 (26974)
2019 (19348)
2018 (14110)
2017 (15598)
2016 (13356)
2015 (16156)
2014 (11644)
2013 (8429)
2012 (8699)
2011 (8850)
2010 (8441)
Location
Africa (182)
Asia (19341)
Australia (3252)
California (3040)
Canada (962)
China (274)
Colorado (126)
Connecticut (124)
Europe (41373)
Florida (351)
Georgia (89)
Illinois (215)
Indiana (100)
Maryland (410)
Massachusetts (2360)
Michigan (86)
Minnesota (136)
New Jersey (755)
New York (844)
North Carolina (499)
Northern California (1322)
Ohio (97)
Pennsylvania (585)
South America (304)
Southern California (1199)
Texas (351)
Washington State (285)
300,996 Results for "expansion therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eterna Therapeutics Announces Expansion of Scientific Advisory Board
January 28, 2025
·
4 min read
Approvals
AstraZeneca, Daiichi Sankyo Continue ADC Rally With Enhertu Expansion
Enhertu’s label expansion comes on the heels of the FDA’s approval of the partners’ Datroway for a related type of breast cancer.
January 28, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Lilly’s I&I Push Gains Momentum With Omvoh Expansion
Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according to analysts from BMO Capital Markets.
January 16, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of death by 20%.
December 12, 2024
·
1 min read
·
Kate Goodwin
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
Press Releases
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
November 21, 2024
·
4 min read
Press Releases
Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases
January 21, 2025
·
7 min read
Press Releases
Flashpoint Therapeutics Announces $50M KAIMRC Partnership and Clinical Pipeline Expansion
November 14, 2024
·
3 min read
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
Rakovina Therapeutics Inc. is pleased to announce the expansion of two research collaborations to align with its recently announced collaboration with the Deep Docking AI Drug Discovery Platform.
May 8, 2024
·
6 min read
1 of 30,100
Next
